Amethyst Radiotherapy Group, a Pan European oncology firm, secured a €300m financing settlement with Credit score funds managed by Ares Administration Company, a worldwide different funding supervisor.
This funding positions Amethyst as a number one participant within the European oncology sector, because it continues to speed up its growth. By broadening its footprint, the corporate goals to convey modern most cancers care to extra sufferers, addressing the escalating demand for accessible and high-quality oncological providers.
Led by Stéphane Carré, CEO, Amethyst Radiotherapy is a personal operator of radiotherapy, offering state-of-the-art most cancers remedy throughout Europe, in six nations. With a give attention to superior know-how and patient-centred care, the corporate is devoted to bettering well being outcomes for most cancers sufferers and to offer an modern and supportive setting for healthcare professionals.
They function 15 centres throughout Austria, France, Italy, Poland, Romania and the UK.
FinSMEs
03/07/2024
